Xie H., Wang Z., Bao A., Goins B., Phillips W.T., Coleman C.L.
Texas Southern University, US
Keywords: cancer, Cu-64, imaging, In-111, nanoshells, PET, radiolabeling, SPECT
Here we report for the first time the radioactive labeling of gold-silica nanoshells with Cu-64 and In-111. A bifunctional polyethylene glycol (PEG2000) is used as crosslinker to connect nanoshells with DOTA or DTPA, which are chelating agents for Cu-64 and In-111respectively. By using Cu-64 for PET/CT imaging and In-111 for SPECT/CT imaging, we monitored the in vivo distribution of Cu64-nanoshells and In111-nanoshells in nude rats with a head and neck squamous cell carcinoma (HNSCC) xenograft. Blood samples were collected at various time points post intravenous injection and the blood clearance of Cu64-nanoshells and In111-nanoshells was determined in terms of radioactive counts. PET and SPECT images of the rats showed that both Cu-64 and In-111 appeared to be useful for tracking the in vivo distribution of nanoshells and both agents appeared to accumulate in the tumor. Overall image quality appeared better with Cu-64 labeling than with In-111 labeling. Therefore, Cu-64 could be a better choice for the tracking of nanoshells in future studies. In summary, this study shows a successful method of conjugating radioactive agents to nanoshells and in vitro and in vivo results support the application of nanoshells for pre-clinical live imaging by using the radioactive agent, Cu-64.
Journal: TechConnect Briefs
Volume: 2, Nanotechnology 2009: Life Sciences, Medicine, Diagnostics, Bio Materials and Composites
Published: May 3, 2009
Pages: 1 - 4
Industry sectors: Advanced Materials & Manufacturing | Medical & Biotech
Topics: Biomaterials, Cancer Nanotechnology
ISBN: 978-1-4398-1783-4